Ignite Creation Date:
2025-12-26 @ 12:17 PM
Ignite Modification Date:
2026-02-27 @ 3:50 PM
Study NCT ID:
NCT00304200
Status:
TERMINATED
Last Update Posted:
2009-02-05
First Post:
2006-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temodar and Sutent as Therapy for Melanoma
Sponsor:
Northern California Melanoma Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Temodar/Sutent
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Lynn E. Spitler, MD, Sponsor/Investigator
Old Organization:
Northern California Melanoma Center